ID   LCSBi007-B
AC   CVCL_A8MF
SY   ND27760-PARK1/SNCA-triplication-clone 3; ND27760-SNCA-triplication-clone 3; ND27760-SNCA3x clone 3; ND27760-clone 3
DR   hPSCreg; LCSBi007-B
DR   Wikidata; Q108820779
RX   PubMed=34826737;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; 11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=34826737).
CC   Omics: Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=34826737; DOI=10.1016/j.scr.2021.102600;
RA   Novak G., Finkbeiner S., Skibinski G., Skupin A.;
RT   "Generation of two human induced pluripotent stem cell lines (iPSCs)
RT   with mutations of the alpha-synuclein (SNCA) gene associated with
RT   Parkinson's disease; the A53T mutation (LCSBi003) and a triplication
RT   of the SNCA gene (LCSBi007).";
RL   Stem Cell Res. 57:102600-102600(2021).
//